Senti Biosciences is trading 6.4% higher at $0.27 in pre-market on October 14, with no clear catalyst identified.
- The stock closed at $0.26 on October 13.
- The company adjourned its annual meeting to allow more time to solicit votes for its merger proposal; the meeting is scheduled to reconvene October 15.
- The filing does not disclose vote counts, so the merger update does not clearly explain the gain.